Title:
バイオアベイラビリティが高いアルボシジブプロドラッグ
Document Type and Number:
Japanese Patent JP7133680
Kind Code:
B2
Abstract:
Compounds having the following structure (I):or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein one of R1, R2 or R3 is -P(=O)(OH)2, and the other two of R1, R2 and R3 are each H, are provided. Pharmaceutical compositions comprising the compounds, and methods for use of the compounds for treating diseases associated with overexpression of a cyclin-dependent kinase (CDK) are also provided.
More Like This:
Inventors:
Adam Siddiqui-Jane
David J. Bearth
David J. Bearth
Application Number:
JP2021079708A
Publication Date:
September 08, 2022
Filing Date:
May 10, 2021
Export Citation:
Assignee:
Sumitomo Pharma Oncology, Incorporated
International Classes:
A61K31/675; A61K9/20; A61K9/48; A61K45/00; A61K47/04; A61K47/12; A61K47/26; A61K47/38; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
JP2004529125A |
Foreign References:
WO2006101846A1 |
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: game machine
Next Patent: Lighting device, sensor unit, reading device and image forming device
Next Patent: Lighting device, sensor unit, reading device and image forming device